More than Half a Million Trees Donated in Six Years, Goal to Plant 50,000 in 2012
(PRWeb May 01, 2012)
Read the full story at http://www.prweb.com/releases/BayerAdvanced/ArborDayFoundation/prweb9463944.htm
COORGA Nutraceuticals Corporation is pleased to announce In-licensing opportunities for Grey Defence®. COORGA Nutraceuticals is looking for international partners in specific countries for...
(PRWeb May 01, 2012)
Read the full story at http://www.prweb.com/releases/2012/5/prweb9459091.htm
Hartz®, one of the country's leading suppliers of flea and tick products for dogs and cats, is proud to announce its new and improved line of popular anti-parasite products, just in time for...
(PRWeb May 01, 2012)
Read the full story at http://www.prweb.com/releases/2012/5/prweb9438811.htm
The Institute for Health Technology Transformation announced today that Jay Srini, Chief Strategist at SCS Ventures has been appointed Senior Fellow & Innovation Chair for the Institute’s 2012...
(PRWeb May 01, 2012)
Read the full story at http://www.prweb.com/releases/2012/5/prweb9458826.htm
*Drugs may be covered by multiple patents
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration |
|---|---|---|---|---|
| LIDODERM | Teikoku Pharma Usa | lidocaine | 5,601,838 | May 2, 2012 |
| LIDODERM | Teikoku Pharma Usa | lidocaine | 5,411,738 | May 2, 2012 |
| TRAVATAN Z | Alcon Pharms Ltd | travoprost | 6,503,497 | May 6, 2012 |
| TRAVATAN Z | Alcon Pharms Ltd | travoprost | 6,849,253 | May 6, 2012 |
| CRIXIVAN | Merck Sharp Dohme | indinavir sulfate | 5,413,999 | May 9, 2012 |
| ALLEGRA | Sanofi Aventis Us | fexofenadine hydrochloride | 6,399,632 | May 11, 2012 |
| CHILDREN’S ALLEGRA ALLERGY | Sanofi Aventis Us | fexofenadine hydrochloride | 6,399,632 | May 11, 2012 |
| CHILDREN’S ALLEGRA HIVES | Sanofi Aventis Us | fexofenadine hydrochloride | 6,399,632 | May 11, 2012 |
| ALLEGRA | Sanofi Aventis Us | fexofenadine hydrochloride | 6,187,791 | May 11, 2012 |
| CHILDREN’S ALLEGRA ALLERGY | Sanofi Aventis Us | fexofenadine hydrochloride | 6,187,791 | May 11, 2012 |
| CHILDREN’S ALLEGRA HIVES | Sanofi Aventis Us | fexofenadine hydrochloride | 6,187,791 | May 11, 2012 |
| AGGRASTAT | Medicure | tirofiban hydrochloride | 5,292,756 | May 14, 2012 |
| COMBIVIR | Viiv Hlthcare | lamivudine; zidovudine | 5,859,021 | May 15, 2012 |
| PLAVIX | Sanofi Aventis Us | clopidogrel bisulfate | 4,847,265*PED | May 17, 2012 |
| ACTONEL WITH CALCIUM (COPACKAGED) | Warner Chilcott | calcium carbonate; risedronate sodium | 6,096,342*PED | May 21, 2012 |
| IMODIUM MULTI-SYMPTOM RELIEF | Mcneil | loperamide hydrochloride; simethicone | 5,716,641 | May 21, 2012 |
| VIRAMUNE | Boehringer Ingelheim | nevirapine | 5,366,972*PED | May 22, 2012 |
| ACTONEL | Warner Chilcott | risedronate sodium | 6,096,342*PED | May 22, 2012 |
| VIRAMUNE XR | Boehringer Ingelheim | nevirapine | 5,366,972*PED | May 22, 2012 |
This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
Recent Comments